SiliconBeat

Maxim Integrated Products, the Sunnyvale chip maker that recently completed a major restatement project caused by a history of incorrectly priced stock option grants, said it expects to report sales of about $500 to $502 million for its fiscal 2009 first quarter ended Sept. 27, slightly below the consensus estimate of $504 in a Thomson Reuters survey. The company said per-share profits would now range from 19 to 22 cents, a bit below the 23 cents most analysts had expected.

The results will include an estimated $30 to $32 million in charges “primarily related to the recently completed restatement and the ramp down of certain wafer fabrication facilities.” We wrote last week about the company’s restatement. At that time, Maxim said that costs for its stock-option investigation and eventual restatement totaled $91.9 million, which didn’t include what the company estimates will be “significant expenses for these costs in fiscal 2009.”

Maxim says it continues to “evaluate various capital structure alternatives” and may increase the the amount of stock it may repurchase to as much as $1.5 billion from the $275 million currently authorized. Its shares fluctuated from a loss to a gain in after-hours trading after rising 79 cents, or 6 percent, to $14.01 in regular trading. They have lost nearly half their value so far this year.